Olink

Olink®
Part of Thermo Fisher Scientific

A single-cell atlas of circulating immune cells over the first 2 months of age in extremely premature infants

Science Translational Medicine, 2025

Olaloye O., Gu W., Gehlhaar A., Sabuwala B., Eke C., Li Y., Kehoe T., Farmer R., Gabernet G., Lucas C., Tsang J., Lakhani S., Taylor S., Tseng G., Kleinstein S., Konnikova L.

Disease areaApplication areaSample typeProducts
Obstetrics
Pathophysiology
Dried Blood Spots
Olink Target 96

Olink Target 96

Abstract

Extremely premature infants (EPIs) who are born before 30 weeks of gestation are susceptible to infection; however, the trajectory of their peripheral immunity is poorly understood. Here, we undertook longitudinal analyses of immune cells from 250 μl of whole blood at 1 week, 1 month, and 2 months from 10 EPIs and compared these with samples from healthy adults and with preterm and full-term cord blood samples. Single-cell suspensions from individual samples were split to perform single-cell RNA sequencing, T and B cell receptor sequencing, and phosphoprotein mass cytometry. The trajectories of circulating T, B, myeloid, and natural killer cells in EPIs over the first 2 months of life were distinct from those of full-term infants. In EPIs, peripheral T cell development rapidly progressed over the first month of life, with an increase in the proportion of naïve CD4 + , regulatory, and cycling T cells, accompanied by greater STAT5 (signal transducer and activator of transcription 5) signaling. EPI memory CD4 + T cells showed a T helper 1 (T H 1) predominance compared with T H 2 skewing of central memory–like T cells in full-term infants, and B cells from 2-month-old EPIs exhibited increased signatures of activation and differentiation. Both B and T cells from 2-month-old EPIs displayed increased interferon signatures compared with cells from full-term infants. In conclusion, we demonstrated the feasibility of longitudinal multiomic analyses in EPIs using minute amounts of blood and developed a resource describing peripheral immune development in EPIs that suggested ongoing activation in early life.

Read publication ↗